11:53 PM EDT, 10/06/2026 (MT Newswires) -- Alvotech (ALVO.IC, ALVO-SDB.ST) and US-based contract development and manufacturing organization Lotte Biologics entered into a new drug substance manufacturing partnership. Lotte Biologics will produce drug substances for several of Alvotech's antibody biosimilar products at its Syracuse facility in New York, US, according to a Tuesday release. The biosimilar-focused biotechnology company added that commercial supply will begin after successful technology transfer, manufacturing qualification, and regulatory approvals.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.